John Libbey Eurotext

Hépato-Gastro & Oncologie Digestive

MENU

At last, an effective molecule combination with gemcitabine in metastatic pancreatic adenocarcinoma, Abraxane® (nab-paclitaxel) Volume 21, issue 3, Mars 2014

Figures

  • Figure 1
  • Figure 2
Author
CHU de Poitiers, service d’hépato-gastro-entérologie, 2 rue de la Milétrie, 86000 Poitiers Cedex, France

Von Hoff DD, Ervin T, Arena FP, et al. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N Engl J Med 2013 ; 369 : 1691-703.